Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss availability, eligibility and decisions regarding clinical trials and the differences in treatment options. This is part six of a nine-part series.
Dr. Growden explains that carcinosarcomas are generally excluded from clinical trials, although uterine carcinosarcoma has been allowed in some trials. Soon, they are going to be opening clinical trials that do include ovarian carcinosarcoma.
Read the video transcript: Click here